Endoglin-Mediated Suppression of Prostate Cancer Invasion Is Regulated by Activin and Bone Morphogenetic Protein Type II Receptors

Michael J. Breen(Norwegian Institute of Marine Research), Raymond C. Bergan(University of Nebraska Medical Center)
PLoS ONE
August 13, 2013
Cited by 23


Related Papers